Candour Techtex Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 3, 2025, 11:17 pm

Competitors of Candour Techtex Ltd

All Competitor Stocks of Candour Techtex Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:37 am

Below is a detailed analysis of the quarterly data for Candour Techtex Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 53.82 Cr.. The value appears strong and on an upward trend. It has increased from 46.43 Cr. (Dec 2024) to 53.82 Cr., marking an increase of 7.39 Cr..
• For Expenses, as of Mar 2025, the value is 53.78 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 44.48 Cr. (Dec 2024) to 53.78 Cr., marking an increase of 9.30 Cr..
• For Operating Profit, as of Mar 2025, the value is 0.04 Cr.. The value appears to be declining and may need further review. It has decreased from 1.95 Cr. (Dec 2024) to 0.04 Cr., marking a decrease of 1.91 Cr..
• For OPM %, as of Mar 2025, the value is 0.07%. The value appears to be declining and may need further review. It has decreased from 4.20% (Dec 2024) to 0.07%, marking a decrease of 4.13%.
• For Other Income, as of Mar 2025, the value is 0.75 Cr.. The value appears strong and on an upward trend. It has increased from 0.22 Cr. (Dec 2024) to 0.75 Cr., marking an increase of 0.53 Cr..
• For Interest, as of Mar 2025, the value is 0.63 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.75 Cr. (Dec 2024) to 0.63 Cr., marking a decrease of 0.12 Cr..
• For Depreciation, as of Mar 2025, the value is 0.98 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.98 Cr..
• For Profit before tax, as of Mar 2025, the value is -0.82 Cr.. The value appears to be declining and may need further review. It has decreased from 0.44 Cr. (Dec 2024) to -0.82 Cr., marking a decrease of 1.26 Cr..
• For Tax %, as of Mar 2025, the value is -9.76%. The value appears to be improving (decreasing) as expected. It has decreased from 36.36% (Dec 2024) to -9.76%, marking a decrease of 46.12%.
• For Net Profit, as of Mar 2025, the value is -0.74 Cr.. The value appears to be declining and may need further review. It has decreased from 0.28 Cr. (Dec 2024) to -0.74 Cr., marking a decrease of 1.02 Cr..
• For EPS in Rs, as of Mar 2025, the value is -0.41. The value appears to be declining and may need further review. It has decreased from 0.17 (Dec 2024) to -0.41, marking a decrease of 0.58.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 3:42 am

Growth

Last Updated: September 5, 2025, 2:46 pm

Balance Sheet

Last Updated: July 25, 2025, 1:38 pm

Below is a detailed analysis of the balance sheet data for Candour Techtex Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2024) to 18.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 21.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2024) to 21.00 Cr., marking an increase of 10.00 Cr..
• For Borrowings, as of Mar 2025, the value is 29.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 38.00 Cr. (Mar 2024) to 29.00 Cr., marking a decrease of 9.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 12.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.00 Cr. (Mar 2024) to 12.00 Cr., marking an increase of 4.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 80.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 74.00 Cr. (Mar 2024) to 80.00 Cr., marking an increase of 6.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 48.00 Cr.. The value appears to be declining and may need further review. It has decreased from 51.00 Cr. (Mar 2024) to 48.00 Cr., marking a decrease of 3.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 31.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Mar 2024) to 31.00 Cr., marking an increase of 9.00 Cr..
• For Total Assets, as of Mar 2025, the value is 80.00 Cr.. The value appears strong and on an upward trend. It has increased from 74.00 Cr. (Mar 2024) to 80.00 Cr., marking an increase of 6.00 Cr..

However, the Borrowings (29.00 Cr.) are higher than the Reserves (21.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Candour Techtex Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 17, the value is 10.00. This value is within the healthy range. It has increased from 1.00 (Mar 16) to 10.00, marking an increase of 9.00.
• For Basic EPS (Rs.), as of Mar 17, the value is 0.22. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 16) to 0.22, marking an increase of 0.22.
• For Diluted EPS (Rs.), as of Mar 17, the value is 0.22. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 16) to 0.22, marking an increase of 0.22.
• For Cash EPS (Rs.), as of Mar 17, the value is 0.53. This value is below the healthy minimum of 3. It has increased from 0.02 (Mar 16) to 0.53, marking an increase of 0.51.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 17, the value is 13.86. It has increased from 1.36 (Mar 16) to 13.86, marking an increase of 12.50.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 17, the value is 13.86. It has increased from 1.36 (Mar 16) to 13.86, marking an increase of 12.50.
• For Revenue From Operations / Share (Rs.), as of Mar 17, the value is 33.25. It has increased from 0.78 (Mar 16) to 33.25, marking an increase of 32.47.
• For PBDIT / Share (Rs.), as of Mar 17, the value is 0.65. This value is below the healthy minimum of 2. It has increased from 0.02 (Mar 16) to 0.65, marking an increase of 0.63.
• For PBIT / Share (Rs.), as of Mar 17, the value is 0.34. This value is within the healthy range. It has increased from 0.00 (Mar 16) to 0.34, marking an increase of 0.34.
• For PBT / Share (Rs.), as of Mar 17, the value is 0.32. This value is within the healthy range. It has increased from 0.00 (Mar 16) to 0.32, marking an increase of 0.32.
• For Net Profit / Share (Rs.), as of Mar 17, the value is 0.21. This value is below the healthy minimum of 2. It has increased from 0.00 (Mar 16) to 0.21, marking an increase of 0.21.
• For NP After MI And SOA / Share (Rs.), as of Mar 17, the value is 0.21. This value is below the healthy minimum of 2. It has increased from 0.00 (Mar 16) to 0.21, marking an increase of 0.21.
• For PBDIT Margin (%), as of Mar 17, the value is 1.97. This value is below the healthy minimum of 10. It has decreased from 2.87 (Mar 16) to 1.97, marking a decrease of 0.90.
• For PBIT Margin (%), as of Mar 17, the value is 1.03. This value is below the healthy minimum of 10. It has increased from 0.13 (Mar 16) to 1.03, marking an increase of 0.90.
• For PBT Margin (%), as of Mar 17, the value is 0.96. This value is below the healthy minimum of 10. It has increased from 0.10 (Mar 16) to 0.96, marking an increase of 0.86.
• For Net Profit Margin (%), as of Mar 17, the value is 0.66. This value is below the healthy minimum of 5. It has increased from 0.19 (Mar 16) to 0.66, marking an increase of 0.47.
• For NP After MI And SOA Margin (%), as of Mar 17, the value is 0.66. This value is below the healthy minimum of 8. It has increased from 0.19 (Mar 16) to 0.66, marking an increase of 0.47.
• For Return on Networth / Equity (%), as of Mar 17, the value is 1.58. This value is below the healthy minimum of 15. It has increased from 0.11 (Mar 16) to 1.58, marking an increase of 1.47.
• For Return on Capital Employeed (%), as of Mar 17, the value is 2.44. This value is below the healthy minimum of 10. It has increased from 0.07 (Mar 16) to 2.44, marking an increase of 2.37.
• For Return On Assets (%), as of Mar 17, the value is 1.30. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 16) to 1.30, marking an increase of 1.26.
• For Long Term Debt / Equity (X), as of Mar 17, the value is 0.01. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 16) to 0.01, marking an increase of 0.01.
• For Total Debt / Equity (X), as of Mar 17, the value is 0.01. This value is within the healthy range. It has increased from 0.00 (Mar 16) to 0.01, marking an increase of 0.01.
• For Asset Turnover Ratio (%), as of Mar 17, the value is 1.29. It has increased from 0.00 (Mar 16) to 1.29, marking an increase of 1.29.
• For Current Ratio (X), as of Mar 17, the value is 4.10. This value exceeds the healthy maximum of 3. It has increased from 1.43 (Mar 16) to 4.10, marking an increase of 2.67.
• For Quick Ratio (X), as of Mar 17, the value is 3.06. This value exceeds the healthy maximum of 2. It has increased from 1.27 (Mar 16) to 3.06, marking an increase of 1.79.
• For Inventory Turnover Ratio (X), as of Mar 17, the value is 1.14. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 16) to 1.14, marking an increase of 1.14.
• For Interest Coverage Ratio (X), as of Mar 17, the value is 30.01. This value is within the healthy range. It has decreased from 141.47 (Mar 16) to 30.01, marking a decrease of 111.46.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 17, the value is 11.04. This value is within the healthy range. It has increased from 10.72 (Mar 16) to 11.04, marking an increase of 0.32.
• For Enterprise Value (Cr.), as of Mar 17, the value is 19.05. It has increased from 8.26 (Mar 16) to 19.05, marking an increase of 10.79.
• For EV / Net Operating Revenue (X), as of Mar 17, the value is 0.35. This value is below the healthy minimum of 1. It has decreased from 0.65 (Mar 16) to 0.35, marking a decrease of 0.30.
• For EV / EBITDA (X), as of Mar 17, the value is 17.96. This value exceeds the healthy maximum of 15. It has decreased from 22.73 (Mar 16) to 17.96, marking a decrease of 4.77.
• For MarketCap / Net Operating Revenue (X), as of Mar 17, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 1.27 (Mar 16) to 0.50, marking a decrease of 0.77.
• For Price / BV (X), as of Mar 17, the value is 1.20. This value is within the healthy range. It has increased from 0.72 (Mar 16) to 1.20, marking an increase of 0.48.
• For Price / Net Operating Revenue (X), as of Mar 17, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 1.27 (Mar 16) to 0.50, marking a decrease of 0.77.
• For EarningsYield, as of Mar 17, the value is 0.01. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 16) to 0.01, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness